Linda Dodds1, Christy G Woolcott1, Hope Weiler2, Anne Spencer1, Jean-Claude Forest3, B Anthony Armson4, Yves Giguère3. 1. Perinatal Epidemiology Research Unit, Departments of Obstetrics & Gynaecology and Pediatrics, Dalhousie University and IWK Health Centre, Halifax, NS, Canada. 2. School of Dietetics and Human Nutrition, McGill University, Sainte-Anne-de-Bellevue, QC, Canada. 3. Department of Molecular Biology, Medical Biochemistry and Pathology, CHU de Québec Research Centre, Université Laval, Quebec City, QC, Canada. 4. Department of Obstetrics & Gynaecology, Dalhousie University and IWK Health Centre, Halifax, NS, Canada.
Abstract
BACKGROUND: Vitamin D status, as measured by serum 25-hydroxyvitamin D (25(OH)D), has been shown in some studies to be inversely associated with gestational diabetes risk. Recently, it has been suggested that maternal smoking status may modify this relationship. We explored the association between 25(OH)D concentration and gestational diabetes and determined if there was an interaction between smoking and 25(OH)D. METHODS: A nested case-control study was conducted in Halifax, Nova Scotia and Quebec City, Quebec. Women were recruited before 20 weeks gestation and 25(OH)D was measured. Cases were women who developed gestational diabetes and controls were frequency matched to cases on study site, gestational age at blood draw, and season and year of blood draw. Logistic regression models estimated adjusted odds ratios (aOR) and 95% confidence intervals (CI). Models were tested for multiplicative and additive interaction, which was estimated by relative excess risk due to interaction (RERI). RESULTS: The study included 395 gestational diabetes cases and 1925 controls. Women who smoked during pregnancy and had 25(OH)D concentrations <30 nmol/L had an aOR = 3.73 [95% CI 1.95, 7.14] compared to non-smokers with 25(OH)D concentrations ≥50 nmol/L. Additive interaction was detected between smoking status and 25(OH)D [RERI = 2.44, 95% CI 0.03, 4.85]. CONCLUSION: Our study supports the inverse association of vitamin D status with gestational diabetes risk, particularly among women who smoke during pregnancy. More research is needed to confirm this finding and, if confirmed, to determine the mechanism by which the combined effect of smoking and low vitamin D status increases the risk of developing gestational diabetes.
BACKGROUND:Vitamin D status, as measured by serum 25-hydroxyvitamin D (25(OH)D), has been shown in some studies to be inversely associated with gestational diabetes risk. Recently, it has been suggested that maternal smoking status may modify this relationship. We explored the association between 25(OH)D concentration and gestational diabetes and determined if there was an interaction between smoking and 25(OH)D. METHODS: A nested case-control study was conducted in Halifax, Nova Scotia and Quebec City, Quebec. Women were recruited before 20 weeks gestation and 25(OH)D was measured. Cases were women who developed gestational diabetes and controls were frequency matched to cases on study site, gestational age at blood draw, and season and year of blood draw. Logistic regression models estimated adjusted odds ratios (aOR) and 95% confidence intervals (CI). Models were tested for multiplicative and additive interaction, which was estimated by relative excess risk due to interaction (RERI). RESULTS: The study included 395 gestational diabetes cases and 1925 controls. Women who smoked during pregnancy and had 25(OH)D concentrations <30 nmol/L had an aOR = 3.73 [95% CI 1.95, 7.14] compared to non-smokers with 25(OH)D concentrations ≥50 nmol/L. Additive interaction was detected between smoking status and 25(OH)D [RERI = 2.44, 95% CI 0.03, 4.85]. CONCLUSION: Our study supports the inverse association of vitamin D status with gestational diabetes risk, particularly among women who smoke during pregnancy. More research is needed to confirm this finding and, if confirmed, to determine the mechanism by which the combined effect of smoking and low vitamin D status increases the risk of developing gestational diabetes.
Authors: John W McEvoy; Khurram Nasir; Andrew P DeFilippis; Joao A C Lima; David A Bluemke; W Gregory Hundley; R Graham Barr; Matthew J Budoff; Moyses Szklo; Ana Navas-Acien; Joseph F Polak; Roger S Blumenthal; Wendy S Post; Michael J Blaha Journal: Arterioscler Thromb Vasc Biol Date: 2015-03-05 Impact factor: 8.311
Authors: Heather H Burris; Sheryl L Rifas-Shiman; Ken Kleinman; Augusto A Litonjua; Susanna Y Huh; Janet W Rich-Edwards; Carlos A Camargo; Matthew W Gillman Journal: Am J Obstet Gynecol Date: 2012-06-01 Impact factor: 8.661
Authors: Dodie L Arnold; Daniel A Enquobahrie; Chungfang Qiu; Jonathan Huang; Nancy Grote; Ann VanderStoep; Michelle A Williams Journal: Paediatr Perinat Epidemiol Date: 2015-03-23 Impact factor: 3.980
Authors: Linda Dodds; Deshayne B Fell; Kent C Dooley; B Anthony Armson; Alexander C Allen; Bassam A Nassar; Sherry Perkins; K S Joseph Journal: Clin Chem Date: 2007-12-10 Impact factor: 8.327
Authors: Minna Sucksdorff; Alan S Brown; Roshan Chudal; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Keely Cheslack-Postava; David Gyllenberg; Andre Sourander Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-12-19 Impact factor: 8.829